; or (ii) otherwise be disclosed or distributed to any party without the written consent of the Secretary and the person submitting such information to the Secretary. (B) Treatment of information under Privacy Act and FOIA A report submitted to the Secretary under this section, shall be considered to be a record about an individual under section 552a of title 5, United States Code (commonly referred to as the ‘‘Privacy Act of 1974’’) and a medical or similar file the disclosure of which would constitute a violation of section 552 of such title 5 (commonly referred to as the ‘‘Freedom of Information Act’’), and shall not be publicly disclosed unless all personally identifiable information is redacted. 623. Nonconfidential information (a) Information available to public Subject to subsection (c) and section 622(d)(2) , all nonconfidential information submitted pursuant to this subchapter shall be made available to the public, including the following types of information: (1) The name, identity, and structure of a chemical substance, contaminant, or impurity that is an ingredient. (2) All information concerning function, exposure, toxicity data, health hazards, and environmental hazards for a cosmetic. (3) The functions of ingredients in cosmetics. (4) Fragrance, flavor, and colorants in a cosmetic. (b) Confidential information The concentration of cosmetic ingredients used in a finished cosmetic shall be considered confidential business information and may not be made available to the public under subsection (a) . (c) Petition for information To remain confidential (1) In general The Secretary shall create a process for an entity to petition for nonconfidential information described in subsection (a) to remain confidential if the entity shows that there would be a serious negative impact to the entity’s commercial interests if such information were disclosed to the public. (2) Limitation The Secretary may not approve a petition under paragraph (1) to the extent that such petition would prevent the public disclosure